title: ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose.
abstract: The transcription of genes encoding proteins involved in the hepatic synthesis of lipids from glucose is strongly stimulated by carbohydrate feeding. It is now well established that in the liver, glucose is the main activator of the expression of this group of genes, with insulin having only a permissive role. While ADD1/SREBP-1 has been implicated in lipogenic gene expression through temporal association with food intake and ectopic gain-of-function experiments, no genetic evidence for a requirement for this factor in glucose-mediated gene expression has been established. We show here that the transcription of ADD1/SREBP-1c in primary cultures of hepatocytes is controlled positively by insulin and negatively by glucagon and cyclic AMP, establishing a link between this transcription factor and carbohydrate availability. Using adenovirus-mediated transfection of a powerful dominant negative form of ADD1/SREBP-1c in rat hepatocytes, we demonstrate that this factor is absolutely necessary for the stimulation by glucose of L-pyruvate kinase, fatty acid synthase, S14, and acetyl coenzyme A carboxylase gene expression. These results demonstrate that ADD1/SREBP-1c plays a crucial role in mediating the expression of lipogenic genes induced by glucose and insulin.
authors: U465 INSERM, Institut Biomédical des Cordeliers, 75270 Paris Cedex 06, France.
authors: M
authors: M
authors: Foretz
authors: C
authors: C
authors: Pacot
authors: I
authors: I
authors: Dugail
authors: P
authors: P
authors: Lemarchand
authors: C
authors: C
authors: Guichard
authors: X
authors: X
authors: Le Lièpvre
authors: C
authors: C
authors: Berthelier-Lubrano
authors: B
authors: B
authors: Spiegelman
authors: J B
authors: JB
authors: Kim
authors: P
authors: P
authors: Ferré
authors: F
authors: F
authors: Foufelle
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D022762:CCAAT-Enhancer-Binding Proteins; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology*; D006019:Glycolysis / Q000235:genetics; D006651:Histocytochemistry; D007328:Insulin / Q000494:pharmacology; D008055:Lipids / Q000096:biosynthesis*; D008099:Liver / Q000378:metabolism*; D009687:Nuclear Proteins / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors; D015533:Transcriptional Activation / Q000235:genetics*; D014162:Transfection
chemical_list: D022762:CCAAT-Enhancer-Binding Proteins; D004268:DNA-Binding Proteins; D007328:Insulin; D008055:Lipids; D009687:Nuclear Proteins; D012333:RNA, Messenger; C497389:Srebf1 protein, rat; D051780:Sterol Regulatory Element Binding Protein 1; D014157:Transcription Factors; D005934:Glucagon; D000242:Cyclic AMP; D005947:Glucose